Advertisement Micrus acquires rights to Genesis's Catheter - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Micrus acquires rights to Genesis’s Catheter

Micrus Endovascular and Genesis Medical Interventional have entered into an agreement granting Micrus the rights to Genesis's F A S T Funnel Catheter and clot retrieval system for the treatment of ischemic stroke.

The transaction includes an initial upfront payment, future development milestone payments and an undisclosed royalty on potential future products sales. The Genesis F A S T Funnel Catheter System is a line of innovative medical devices comprised of a funnel deployed at the distal end of the catheter through which a physician can deploy a proprietary clot retrieval system with an umbrella or parachute-like device.

John Kilcoyne, chairman and CEO of Micrus, said: “The F A S T Funnel Catheter system is designed to quickly and easily facilitate the endovascular removal of blood clots and other obstructions while potentially eliminating the limitations inherent in other clot retrieval devices.”